Equities Analysts Issue Forecasts for Tilray FY2028 Earnings

Tilray Inc (NASDAQ:TLRY) – Equities researchers at Atb Cap Markets lowered their FY2028 earnings per share (EPS) estimates for shares of Tilray in a report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of $0.01 for the year, down from their previous forecast of $0.06. The consensus estimate for Tilray’s current full-year earnings is ($0.14) per share.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The company had revenue of $200.00 million for the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company’s revenue was up 13.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.10) earnings per share.

Separately, Roth Mkm lowered their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Tilray Stock Down 6.5 %

Tilray stock opened at $1.16 on Wednesday. Tilray has a twelve month low of $1.15 and a twelve month high of $2.97. The stock has a market cap of $1.05 billion, a P/E ratio of -4.30 and a beta of 2.08. The company’s 50-day moving average price is $1.46 and its two-hundred day moving average price is $1.66. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.

Hedge Funds Weigh In On Tilray

Several hedge funds have recently bought and sold shares of the company. Bank of Montreal Can increased its stake in Tilray by 0.3% in the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock valued at $3,787,000 after acquiring an additional 7,406 shares during the last quarter. State Street Corp increased its stake in shares of Tilray by 4.7% in the 3rd quarter. State Street Corp now owns 1,961,338 shares of the company’s stock valued at $3,452,000 after purchasing an additional 88,079 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after buying an additional 1,690,827 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Tilray by 6.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock worth $2,953,000 after buying an additional 107,530 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in Tilray by 2.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,487,500 shares of the company’s stock valued at $2,617,000 after buying an additional 37,300 shares in the last quarter. 9.35% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CFO Carl A. Merton purchased 26,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, with a total value of $35,360.00. Following the completion of the purchase, the chief financial officer now directly owns 26,000 shares in the company, valued at $35,360. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.87% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.